2020
-
New head of the Danish Medicines Agency’s Data Analytics Centre
| 05 March 2020 |
The Danish Medicines Agency has hired Jesper Kjær as head of the Agency’s Data Analytics Centre as of 1 April. The Data Analytics Centre will officially open later this year.
-
The authorities are getting ready for fast-track approval of vaccines for coronavirus
| 17 February 2020 |
Drug regulatory authorities around the world are supporting researchers and companies in the fast development of a vaccine for coronavirus (2019-nCoV) and are getting ready to facilitate an approval as fast as possible without compromising safety.
-
Danish Medicines Agency's top priorities in 2020
| 08 January 2020 |
A data-driven medicines agency, the continued supply of medicines, a great place to work and productivity and quality are the top priorities for the Danish Medicines Agency in 2020.
-
Updating of summaries of product characteristics due to changed ATC codes for 2020
| 08 January 2020 |
Marketing authorisation holders of medicinal products authorised under the national procedure, the decentralised procedure as well as the mutual recognition procedure should be aware that some ATC codes have been changed for 2020.
-
Danish Medicines Agency shortens the review time for applications for COVID-19 medicine trials
Drug regulatory authorities around the world are taking several steps to speed up the development and availability of medicines to treat and prevent novel COVID-19. The Danish Medicines Agency in Denmark has just implemented an emergency procedure for applications for clinical trials with human subjects.
-
EMA: No evidence linking ibuprofen to worsening of COVID-19
The press and social media have raised questions about whether ibuprofen could worsen the condition of patients infected with COVID-19. The European Medicines Agency reports that there is currently no scientific evidence to suggest this. The Data Analytics Center of the Danish Medicines Agency now launches an ultra-quick study.
-
Henstilling om, hvordan præparatet remdesivir skal bruges til behandling af COVID-19 i såkaldt compassionate use-programs i EU
Under et ekstraordinært møde, der blev afholdt den 2. april 2020, gav det europæiske medicinalagentur EMA's humane lægemiddeludvalg (CHMP) henstillinger om, hvordan præparatet remdesivir skal bruges til behandling af COVID-19 i såkaldt compassionate use-programs i EU, dvs. via udleveringstilladelser.
-
COVID-19: Restriction on OTC medicines lifted
The Danish Medicines Agency lifts the restriction on over-the-counter (OTC), which has been in force since March. This means that pharmacies, supermarkets, kiosks and others with permission to sell OTC medicines can resume selling more than one pack of the same type of OTC medicine per customer.